Ting Xu

机构：Sun Yat-sen University, Capital Medical University, Peking University, XinHua Hospital, Biomarker Technologies (China), Beijing Tian Tan Hospital, Peking University Cancer Hospital, The First Affiliated Hospital, Sun Yat-sen University, Shanghai Children's Hospital, Inner Mongolia Medical University · ORCID：0000-0002-1381-1609

发表论文 81 篇 · 总被引 607 次 · h-index 14

代表论文

• SPP1 Drives Colorectal Cancer Liver Metastasis and Immunotherapy Resistance by Stimulating CXCL12 Production in Cancer-Associated Fibroblasts (2025 · Cancer Research · 被引 26)
• Current data and future perspectives on DNA methylation in ovarian cancer (Review) (2024 · International Journal of Oncology · 被引 17)
• Evolutionary divergence in CTCF-mediated chromatin topology drives transcriptional innovation in humans (2025 · Nature Communications · 被引 11)
• Blood RNA-seq in rare disease diagnostics: a comparative study of cases with and without candidate variants (2025 · Journal of Translational Medicine · 被引 10)
• Immune checkpoint inhibitor-induced colitis with endoscopic evaluation in Chinese cancer patients: a single-centre retrospective study (2023 · Frontiers in Oncology · 被引 7)
• Janus kinase inhibitors and the risk of infections: a network meta-analysis across disease indications (2025 · Expert Opinion on Drug Safety · 被引 6)